Kura Oncology, Inc. (KURA) — Dilution Risk Analysis

Current Snapshot

Kura Oncology, Inc. (KURA) has a DilutionWatch score of 50/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
88,960,619 Source
Public Float
70,263,134 Source
Float as % of Outstanding
79.0%

Dilution Risk Score

Score: 50/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: 4 10.

FormFiledAccession
4 2026-01-27 0001193125-26-025301
4 2026-01-27 0001193125-26-025306
4 2026-01-27 0001193125-26-025302
4 2026-01-27 0001193125-26-025303
4 2026-01-27 0001193125-26-025304
4 2026-01-27 0001193125-26-025305
4 2026-01-06 0001193125-26-004562
4 2026-01-06 0001193125-26-004564
4 2026-01-06 0001193125-26-004566
4 2026-01-06 0001193125-26-004567

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 3 months Source
Three-year share count growth 19.78% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 50/10) Source
Cash Runway
3 months Source
Share Count Growth (3-Year)
19.78% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.